Variables | OR | Lower Bound, 95% CI | Upper Bound, 95% CI | p |
---|---|---|---|---|
*Living Combination | ||||
IRF-LTCH-SNF | Ref. | |||
SNF-only | 5.443 | 5.318 | 5.571 | < 0.001 |
LTCH-SNF | 4.043 | 3.835 | 4.262 | < 0.001 |
IRF-only | 6.796 | 3.754 | 12.303 | < 0.001 |
IRF-SNF | 1.397 | 1.363 | 1.432 | < 0.001 |
*Age, yrs | ||||
21–64 | 0.986 | 0.942 | 1.033 | 0.621 |
65–69 | Ref. | |||
70–74 | 0.936 | 0.901 | 0.971 | 0.003 |
75–79 | 0.856 | 0.825 | 0.887 | < 0.001 |
80–84 | 0.727 | 0.702 | 0.754 | < 0.001 |
85+ | 0.622 | 0.601 | 0.643 | < 0.001 |
*Race | ||||
Non-Hispanic White | Ref. | |||
Non-Hispanic Black | 1.058 | 1.027 | 1.089 | 0.001 |
Hispanic | 1.138 | 1.090 | 1.188 | < 0.001 |
Other | 1.333 | 1.269 | 1.401 | < 0.001 |
*Sex | ||||
Male | Ref. | |||
Female | 0.960 | 0.942 | 0.978 | < 0.001 |
Stroke Type | ||||
Ischemic | Ref. | |||
Hemorrhagic | 1.012 | 0.983 | 1.043 | 0.493 |
*Acute LOS, days | ||||
0–3 | Ref. | |||
4–7 | 1.030 | 1.010 | 1.051 | 0.015 |
8–11 | 1.032 | 1.000 | 1.065 | 0.098 |
12–25 | 1.089 | 1.045 | 1.135 | 0.001 |
26+ | 1.185 | 1.038 | 1.353 | 0.035 |
*Dual Eligible | ||||
No | Ref. | |||
Yes | 0.769 | 0.752 | 0.787 | < 0.001 |
*ICU/CCU | ||||
No | Ref. | |||
Yes | 1.259 | 1.236 | 1.283 | < 0.001 |
*Hemiplegia/Hemiparesis | 1.191 | 1.169 | 1.213 | < 0.001 |
Specified Heart Arrhythmias | 0.998 | 0.978 | 1.018 | 0.856 |
*Diabetes without Complications | 0.969 | 0.949 | 0.989 | 0.011 |
Congestive Heart Failure | 0.982 | 0.960 | 1.004 | 0.176 |
*Acute Renal Failure | 1.041 | 1.015 | 1.068 | 0.008 |
*Chronic Obstructive Pulmonary Disease | 0.920 | 0.897 | 0.943 | < 0.001 |
Vascular Disease | 0.994 | 0.967 | 1.022 | 0.715 |
*Diabetes with Chronic Complications | 0.935 | 0.903 | 0.969 | 0.002 |
*Seizure Disorders and Convulsions | 0.916 | 0.885 | 0.948 | < 0.001 |
Cardio-Respiratory Failure and Shock | 1.003 | 0.966 | 1.042 | 0.881 |